Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers
The purpose of this study is to study the effect of the drug DCA (dichloroacetate) on recurrent head and neck cancers. Part of this study will also use EF5 PET scan to study tumor hypoxia.
Head and Neck Cancer|Head and Neck Cancers
DRUG: Dichloroacetate|DEVICE: EF5
To determine the maximum tolerated dose of DCA in patients with recurrent head and neck cancer who have failed first-line therapy., Duration of study
The purpose of this study is to study the effect of the drug DCA (dichloroacetate) on recurrent head and neck cancers. Part of this study will also use EF5 PET scan to study tumor hypoxia.